REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer.
Saved in:
| Title: | REaCT-5G: a randomized trial of bone pain with 5-day filgrastim vs pegfilgrastim for neutropenia in breast cancer. |
|---|---|
| Authors: | Ng TL; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Greenstreet P; Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Stober C; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Nicholls S; Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Office for Patient Engagement in Research Activity, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Shamess J; Champlain Regional Cancer Care Patient and Family Advisory Council, Ottawa, ON, Canada., Mills N; St Joseph Family Medical Clinic, Ottawa, ON, Canada., Ibrahim M; Department of Medical Oncology, Northern Ontario School of Medicine University, Thunder Bay, ON, Canada.; Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada., Savard MF; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Rushton M; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Awan A; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Sehdev S; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Hilton J; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Song X; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Fallah P; Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada., Alqahtani N; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Department of Medicine, King Abdulaziz Hospital, Alhasa, Saudi Arabia., Davoudpour D; Thunder Bay Regional Health Sciences Centre, Thunder Bay, ON, Canada., Daigle K; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., MacDonald F; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada., Vandermeer L; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Taljaard M; Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada., Clemons M; Division of Medical Oncology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.; Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada. |
| Source: | JNCI cancer spectrum [JNCI Cancer Spectr] 2025 Sep 01; Vol. 9 (5). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2515-5091 |
|---|---|
| DOI: | 10.1093/jncics/pkaf081 |
